Renewable Cell Source Could Make Cancer Immunotherapy Treatments Available Off-the-Shelf

Researchers at USC Stem Cell have developed a breakthrough method to generate renewable and expandable progenitor cells that develop into macrophages, immune cells crucial for fighting cancer and other diseases. Published in Cell, this discovery could transform cancer immunotherapy by enabling the production of standardized, off-the-shelf treatments rather than patient-specific therapies. Macrophages play a vital role in the body's immune response against pathogens and tumors. This advancement promises to make immunotherapy more accessible and cost-effective for cancer patients across Puerto Rico and beyond, potentially revolutionizing how immunotherapy is administered in clinical practice.